CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $71,502,000 | +3.0% | 10,200,000 | +21.8% | 1.25% | -7.1% |
Q1 2022 | $69,404,000 | +7.1% | 8,372,000 | -12.5% | 1.34% | +26.5% |
Q4 2021 | $64,802,000 | +22.3% | 9,572,000 | -4.3% | 1.06% | +18.2% |
Q3 2021 | $53,000,000 | -7.8% | 10,000,000 | 0.0% | 0.90% | -12.7% |
Q2 2021 | $57,500,000 | +24.7% | 10,000,000 | 0.0% | 1.03% | -2.7% |
Q1 2021 | $46,100,000 | +38.0% | 10,000,000 | 0.0% | 1.06% | -6.9% |
Q4 2020 | $33,400,000 | +12.5% | 10,000,000 | 0.0% | 1.14% | +5.5% |
Q3 2020 | $29,700,000 | +3.7% | 10,000,000 | +61.3% | 1.08% | -14.3% |
Q2 2020 | $28,644,000 | +37.8% | 6,200,000 | +14.8% | 1.26% | -2.3% |
Q1 2020 | $20,790,000 | +8.7% | 5,400,000 | +5.9% | 1.29% | +16.6% |
Q4 2019 | $19,125,000 | -0.4% | 5,100,000 | +2.0% | 1.10% | -8.8% |
Q2 2019 | $19,200,000 | +147.7% | 5,000,000 | +228.9% | 1.21% | +185.4% |
Q1 2019 | $7,752,000 | +192.5% | 1,520,000 | +10.1% | 0.42% | +110.9% |
Q4 2018 | $2,650,000 | -58.1% | 1,380,000 | -17.5% | 0.20% | -47.0% |
Q3 2018 | $6,320,000 | +19.2% | 1,672,000 | -1.6% | 0.38% | +9.5% |
Q2 2018 | $5,304,000 | – | 1,700,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |